Literature DB >> 15051698

Current and future concepts in stroke prevention.

Fintan O'Rourke1, Naeem Dean, Naveed Akhtar, Ashfaq Shuaib.   

Abstract

Stroke is a major cause of morbidity and mortality in an aging population. The current understanding of the pathophysiology of atherosclerotic diseases, the most common cause of stroke, and the evidence for existing therapeutic interventions for the prevention of stroke are presented. Specifically, we review the evidence for antiplatelet agents, anticoagulants, antihypertensive medications, lipid-lowering agents and carotid endarterectomy for stroke prevention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051698      PMCID: PMC374221          DOI: 10.1503/cmaj.1031185

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  97 in total

Review 1.  Antithrombotic agents in coronary artery disease.

Authors:  J A Cairns; P Théroux; H D Lewis; M Ezekowitz; T W Meade
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 2.  Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.

Authors:  P D Stein; J S Alpert; H I Bussey; J E Dalen; A G Turpie
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

3.  Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project.

Authors:  R P Byington; B R Davis; J F Plehn; H D White; J Baker; S M Cobbe; J Shepherd
Journal:  Circulation       Date:  2001-01-23       Impact factor: 29.690

4.  Direct proinflammatory effect of C-reactive protein on human endothelial cells.

Authors:  V Pasceri; J T Willerson; E T Yeh
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

5.  Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence.

Authors:  G W Petty; R D Brown; J P Whisnant; J D Sicks; W M O'Fallon; D O Wiebers
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

6.  Short-term prognosis after emergency department diagnosis of TIA.

Authors:  S C Johnston; D R Gress; W S Browner; S Sidney
Journal:  JAMA       Date:  2000-12-13       Impact factor: 56.272

7.  The anti-phospholipid antibody syndrome (Hughes syndrome): therapeutic aspects.

Authors:  M J Cuadrado; M A Khamashta
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  2000-03       Impact factor: 4.098

8.  Physical activity and risk of stroke in women.

Authors:  F B Hu; M J Stampfer; G A Colditz; A Ascherio; K M Rexrode; W C Willett; J E Manson
Journal:  JAMA       Date:  2000-06-14       Impact factor: 56.272

9.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

10.  Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

Authors: 
Journal:  Arch Intern Med       Date:  1994-07-11
View more
  7 in total

1.  Stroke prevention.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2005-08-16       Impact factor: 8.262

Review 2.  Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.

Authors:  Ramya Kapadia; Jae-Hyuk Yi; Raghu Vemuganti
Journal:  Front Biosci       Date:  2008-01-01

3.  Radiation dose from multidetector row CT imaging for acute stroke.

Authors:  Anisa Mnyusiwalla; Richard I Aviv; Sean P Symons
Journal:  Neuroradiology       Date:  2009-06-09       Impact factor: 2.804

4.  RETRACTED: Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy.

Authors:  Natalie Noe; Lloye Dillon; Veronika Lellek; Francisca Diaz; Aline Hida; Carlos T Moraes; Tina Wenz
Journal:  Mitochondrion       Date:  2012-12-20       Impact factor: 4.160

5.  Therapeutic Potential of PPARγ Activation in Stroke.

Authors:  Raghu Vemuganti
Journal:  PPAR Res       Date:  2008-04-13       Impact factor: 4.964

6.  Exploring stroke survivors' self-efficacy in understanding and taking medication and determining associated factors: a cross-sectional study in a neurology clinic in Malaysia.

Authors:  Jamuna Rani Appalasamy; Joyce Pauline Joseph; Siva Seeta Ramaiah; Kia Fatt Quek; Anuar Zaini Md Zain; Kyi Kyi Tha
Journal:  Patient Prefer Adherence       Date:  2019-08-28       Impact factor: 2.711

7.  The Needs and Barriers of Medication-Taking Self-Efficacy Among Poststroke Patients: Qualitative Study.

Authors:  Jamuna Rani Appalasamy; Pathmavathi Subramanian; Kit Mun Tan; Joyce Pauline Joseph; Siew Siang Chua; Siva Seeta Ramaiah
Journal:  JMIR Nurs       Date:  2019-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.